Profile
Xiao Ping Dai is currently the Chief Technical Officer at IVERIC bio, Inc. Prior to this, she worked as the Senior Director-Biologics Development at Celgene Corp.
from 2014 to 2018, and as the Chief Technologist & VP-Technology Development at WuXi Advanced Therapies, Inc. from 2018 to 2019.
She holds a doctorate degree from the New Jersey Institute of Technology.
Xiao Ping Dai active positions
| Companies | Position | Start |
|---|---|---|
| IVERIC BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Xiao Ping Dai
| Companies | Position | End |
|---|---|---|
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Training of Xiao Ping Dai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Health Technology |
- Stock Market
- Insiders
- Xiao Ping Dai
















